Compugen Ltd. (CGEN)

NASDAQ: CGEN · USD

$1.99

+0.02 (+1.0%)· Recorded snapshot

Market cap	188.5M
Revenue (ttm)	74M
Net income (ttm)	35.2M
EPS (ttm)	$0.37
Shares out	94.7M
P/E (trailing)	5.3x
Volume	146,168
Beta	2.79

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 74M
Net income (ttm): 35.2M
EPS (ttm): $0.37
P/E (trailing): 5.3x
Market cap: 188.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	보유

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E5.3

P25 n/aP50 n/aP75 n/a

ROE50.6

P25 n/aP50 n/aP75 n/a

ROIC26.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CGEN indicators

Market & fundamental data

Available fields

233

Groups with data

Currency

USD

Showing 233 of 233 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001119774
Company name	Compugen Ltd.
Country	Israel
Country code	US
CUSIP number	M25722105
Earnings date	2026-11-09
Earnings time	bmo
Employees	75
Employees change	1
Employees growth	1.35%
Enterprise value	$66.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1993
Industry	Biotechnology
IPO date	2000-08-11
Is primary listing	Yes
Is SPAC	No
ISIN number	IL0010852080
Last 10-K release date	2026-03-02
Last earnings date	2026-08-03
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$188.5M
Market cap category	Micro-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$1.99
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	CGEN
Website	https://cgen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	5.24x
Earnings yield	18.76%
EV/Earnings	1.87x
EV/EBIT	2.17x
EV/EBITDA	2.14x
EV/FCF	2.34x
EV/Sales	0.89x
FCF / EV yield	42.79%
FCF yield	14.96%
Forward EV/Sales	12.21x
Forward P/S	34.93x
Graham number	2.80507
Graham upside	41.31%
P/(FCF - SBC) ratio	7.05x
P/(OCF - SBC) ratio	7.02x
P/B ratio	2.1x
P/E ratio	5.33x
P/FCF ratio	6.68x
P/OCF ratio	6.66x
P/S ratio	2.54x
Price / tangible book value	2.12x
Price/EBITDA ratio	6.13x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	40.94%
EBITDA margin	41.45%
Effective tax rate	0.15%
FCF margin	38.02%
Gross margin	86.89%
Operating margin	40.94%
Pretax margin	47.63%
Profit margin	47.55%
Profit per employee	$469,213
Profitable years	1
Revenue per employee	$986,680
ROA	15.46%
ROA (5Y)	-7.35%
ROCE	26.18%
ROE	50.64%
ROE (5Y)	-14.35%
ROIC	26.12%
SBC / revenue	1.98%
Tax / revenue	0.07%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	4
Gross profit growth	365.82%
Gross profit growth 3Y	114.39%
Gross profit growth 5Y	101.41%
Net income growth quarters	1
Net income growth years	4
Revenue growth	234.18%
Revenue growth (Q)	107%
Revenue growth (QoQ)	19.58%
Revenue growth 10Y	23.28%
Revenue growth 3Y	114.48%
Revenue growth 5Y	105.89%
Revenue growth quarters	1
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-116,000
Depreciation and amortization	$380,000
EBIT	$30.3M
EBITDA	$30.7M
EPS	$0.37
FCF per share	$0.30
Financing cash flow	$1.8M
Free cash flow	$28.1M
Free cash flow minus SBC	$26.7M
Gross profit	$64.3M
Income taxes	$52,000
Investing cash flow	$-27M
Net cash flow	$3.8M
Net income	$35.2M
Operating cash flow minus SBC	$26.8M
Operating income	$30.3M
Revenue	$74M
Stock-based compensation	$1.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-0.4
Book value per share	$0.94
Debt / EBITDA	0.1
Debt / equity	0.03
Debt / FCF	0.11
Long-term assets	$9M
Long-term liabilities	$27M
Net cash (debt)	$122.3M
Net cash / market cap	65.03%
Net cash growth	34.51%
Net debt / EBITDA	-3.99
Net debt / equity	-1.38
Net debt / FCF	-4.35
Piotroski F-Score	6
Property, plant and equipment	$3.1M
Shareholders' equity	$88.7M
Tangible book value	$88.7M
Tangible book value per share	$0.94
Total assets	$138.4M
Total cash	$125.3M
Total debt	$3M
Total liabilities	$49.6M
WACC	19.28%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.6
Current assets	$129.4M
Current liabilities	$22.6M
Current ratio	5.72
Net working capital	$-17.9M
Quick ratio	5.72
Working capital	$106.8M
Working capital turnover	0.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.76%
Dividend yield	0%
Shareholder yield	-3.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-64.64%
10Y return CAGR	-9.88%
10Y total return	-64.64%
150-day SMA	$2.41
15Y price change	-54.79%
15Y return CAGR	-5.16%
15Y total return	-54.79%
1D price change	1.02%
1M price change	-16.81%
1M total return	-16.81%
1W price change	-7.48%
1W total return	-7.48%
1Y price change	15.79%
1Y return CAGR	15.8%
1Y total return	15.79%
20-day SMA	$2.08
200-day SMA	$2.30
20Y price change	-30.77%
20Y return CAGR	-1.82%
20Y total return	-30.77%
3M price change	-16.81%
3M total return	-16.81%
3Y price change	190.32%
3Y return CAGR	42.65%
3Y total return	190.32%
50-day SMA	$2.34
50-day SMA vs 200-day SMA	50over200
52-week high	$3.24
52-week high date	2026-04-24
52-week low	$1.43
52-week low date	2025-12-30
5Y price change	-67.65%
5Y return CAGR	-20.21%
5Y total return	-67.65%
6M price change	-32.19%
6M total return	-32.19%
All-time high	$19.90
All-time high date	2020-08-26
All-time low	$0.34
All-time low date	2008-11-24
Average true range (ATR)	$0.10
Average volume	234.2K
Beta (1Y)	1.7
Beta (2Y)	1.43
Beta (5Y)	2.79
Change from 52-week high	-38.49%
Change from 52-week low	39.16%
Change from all-time high	-90.05%
Change from all-time low	482.35%
Change from open	1.02%
Day's gap	0%
Dollar volume	$290,874
High price	$2.01
Low price	$1.97
Monthly RSI	49.03
Open price	$1.97
Position in 52-week range	50%
Premarket change	0%
Premarket close	$1.97
Premarket price	$1.97
Previous close	$1.97
Price vs 150-day SMA	-17.71%
Price vs 20-day SMA	-4.85%
Price vs 200-day SMA	-13.76%
Price vs 50-day SMA	-15.53%
Relative volume	0.62
RSI	40.32
Sharpe ratio	0.48
Sharpe ratio (3Y)	0.65
Sharpe ratio (5Y)	0.15
Sortino ratio	0.88
Sortino ratio (3Y)	1.91
Sortino ratio (5Y)	0.4
Volume	146.2K
Weekly RSI	40.33
YTD price change	29.41%
YTD total return	29.41%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	94.5M
Float percentage	99.78%
Shares change (QoQ)	0.09%
Shares change (YoY)	3.76%
Shares held by insiders	0.22%
Shares held by institutions	16.33%
Shares outstanding	94.7M
Short % of shares	2.49%
Short ratio	13.7 days

Deeper analysis on CGEN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CGEN report

Is a complete CGEN research report available?

No complete published report is available for Compugen Ltd. (CGEN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Compugen Ltd. (CGEN)

Price

Financial snapshot

Fair-value bridge

Latest news · CGEN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CGEN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CGEN

Frequently asked questions